ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 122,58
0,15%
Dow Jones
44 154,65
-1,06%
DAX
22 314,65
-0,54%
Brent Oil
76,155
0,44%
Bitcoin
98 618,29
2,06%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cerus Corp (CERS)

  7. Cerus Corp (CERS) Actualités

CERS

Cerus (CERS)

Cerus Corp
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CERS
DateHeureSourceTitreSymboleSociété
19/02/202522h00Business WireCerus Corporation to Participate in the TD Cowen 45th Annual Health Care ConferenceNASDAQ:CERSCerus Corp
14/02/202517h23Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CERSCerus Corp
07/02/202514h30Business WireCerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025NASDAQ:CERSCerus Corp
06/02/202522h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERSCerus Corp
13/01/202514h30Business WireCerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business UpdateNASDAQ:CERSCerus Corp
02/01/202523h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERSCerus Corp
16/12/202422h17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CERSCerus Corp
13/11/202414h30Business WireCerus Corporation to Participate in Upcoming Investor ConferencesNASDAQ:CERSCerus Corp
12/11/202415h53Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CERSCerus Corp
31/10/202421h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CERSCerus Corp
30/10/202421h00Business WireCerus Corporation Announces Third Quarter 2024 Financial ResultsNASDAQ:CERSCerus Corp
18/10/202414h30Business WireCerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual MeetingNASDAQ:CERSCerus Corp
18/10/202414h30Business WireCerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024NASDAQ:CERSCerus Corp
16/10/202422h00Business WireCerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and EuropeNASDAQ:CERSCerus Corp
01/08/202423h31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CERSCerus Corp
01/08/202422h00Business WireCerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance RangeNASDAQ:CERSCerus Corp
18/07/202414h30Business WireCerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024NASDAQ:CERSCerus Corp
02/07/202422h00Business WireCerus Corporation Announces Appointment of Dean Gregory to Board of DirectorsNASDAQ:CERSCerus Corp
21/06/202414h30Business WireCerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood TransfusionNASDAQ:CERSCerus Corp
14/06/202414h30Business WireCerus Corporation Celebrates World Blood Donor Day 2024NASDAQ:CERSCerus Corp
31/05/202422h01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:CERSCerus Corp
22/05/202414h30Business WireCerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor ConferenceNASDAQ:CERSCerus Corp
02/05/202422h00Business WireCerus Corporation Announces First Quarter 2024 Financial ResultsNASDAQ:CERSCerus Corp
18/04/202414h30Business WireCerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024NASDAQ:CERSCerus Corp
26/03/202413h30Business WireCerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf LifeNASDAQ:CERSCerus Corp
19/03/202413h00Business WireCerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery PatientsNASDAQ:CERSCerus Corp
05/03/202422h58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CERSCerus Corp
05/03/202422h00Business WireCerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:CERSCerus Corp
20/02/202414h30Business WireCerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024NASDAQ:CERSCerus Corp
14/02/202422h21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CERSCerus Corp
 Showing the most relevant articles for your search:NASDAQ:CERS

Dernières Valeurs Consultées

NASDAQ
GOOGL
Alphabet
NASDAQ
AMZN
Amazon.com
COIN
XRPUSD
Ripple
EU
BN
Danone
COIN
AVAXUSD
Avalanche
EU
BNP
BNP Paribas
USI
USTECH100
US Tech 100
COIN
SOLUSD
Solana
NASDAQ
MSFT
Microsoft
NYSE
NKE
Nike
EU
RNO
Renault
COIN
ADAUSD
Cardano
EU
BEL20
Bel 20
NYSE
KO
Coca Cola
EU
AI
Air Liquide
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces